Novolog (Pharm-Up 1966) Ltd
NVLG.TA
Price:
$127.9
Market Cap:
$653.41M
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. It offers medical devices to healthcare institutions and patients in their homes; and medical logistics services to pharmaceutical and medical device companies. The company also produces and disseminates medical content and tools to the general public and medical community; and develops personalized treatment programs and initiates home visits by nurses. In addition, it provides health and medical process management services for corporations; and supplies sterilization services using ethylene oxide gas for medical and laboratory products, as well as offers direct access to health and wellness ecosystem for international corp...[Read more]
Industry
Medical - Care Facilities
IPO Date
2017-02-28
Stock Exchange
TLV
Ticker
NVLG.TA
PE Ratio
[63.95]
ROE
[5.06%]
Current Ratio
[0.96]
Dividend Yield
[3.06%]
Enterprise Value
[625.34M]
Dividend History
The PE Ratio as of December 2025 (TTM) for Novolog (Pharm-Up 1966) Ltd (NVLG.TA) is 63.95
According to Novolog (Pharm-Up 1966) Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 63.95. This represents a change of -42.25% compared to the average of 110.73 of the last 4 quarters.
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) Historical PE Ratio (quarterly & annually)
How has NVLG.TA PE Ratio performed in the past?
The mean historical PE Ratio of Novolog (Pharm-Up 1966) Ltd over the last ten years is 25.66. The current 63.95 PE Ratio has changed 24.82% with respect to the historical average. Over the past ten years (40 quarters), NVLG.TA's PE Ratio was at its highest in in the September 2023 quarter at 685.29. The PE Ratio was at its lowest in in the September 2019 quarter at -40.30.
Average
25.66
Median
24.36
Minimum
-17.25
Maximum
64.46
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Novolog (Pharm-Up 1966) Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 260.13%
Maximum Annual PE Ratio = 64.46
Minimum Annual Increase = -235.64%
Minimum Annual PE Ratio = -17.25
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 23.39 | -235.64% |
| 2023 | -17.25 | -158.32% |
| 2022 | 29.58 | -16.60% |
| 2021 | 35.46 | -0.15% |
| 2020 | 35.51 | -44.90% |
| 2019 | 64.46 | 260.13% |
| 2018 | 17.90 | -29.34% |
| 2017 | 25.33 | 29.31% |
| 2016 | 19.59 | -13.27% |
| 2015 | 22.59 | -7.15% |
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) Average PE Ratio
How has NVLG.TA PE Ratio performed in the past?
The current PE Ratio of Novolog (Pharm-Up 1966) Ltd (NVLG.TA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
11.91
5-year avg
21.34
10-year avg
25.66
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) PE Ratio vs. Peers
How is NVLG.TA’s PE Ratio compared to its peers?
Novolog (Pharm-Up 1966) Ltd’s PE Ratio is greater than Ilex Medical Ltd (17.46), greater than Golden House Ltd (-26.56), greater than Compugen Ltd. (-7.34), greater than Bait Bakfar Ltd (8.97), greater than Merchavia Holdings and Investments Ltd. (-2.66), greater than BATM Advanced Communications Ltd. (-24.28), greater than Oramed Pharmaceuticals Inc. (-5.06), greater than Pulsenmore Ltd. (0.10), less than BrainsWay Ltd. (64.60), greater than InterCure Ltd. (-3.32),
| Company | PE Ratio | Market cap |
|---|---|---|
| 17.46 | $760.23M | |
| -26.56 | $174.10M | |
| -7.34 | $455.52M | |
| 8.97 | $1.03B | |
| -2.66 | $40.94M | |
| -24.28 | $301.41M | |
| -5.06 | $404.33M | |
| 0.10 | $157.25M | |
| 64.60 | $1.03B | |
| -3.32 | $226.38M |
Build a custom stock screener for Novolog (Pharm-Up 1966) Ltd (NVLG.TA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novolog (Pharm-Up 1966) Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Novolog (Pharm-Up 1966) Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Novolog (Pharm-Up 1966) Ltd's PE Ratio?
How is the PE Ratio calculated for Novolog (Pharm-Up 1966) Ltd (NVLG.TA)?
What is the highest PE Ratio for Novolog (Pharm-Up 1966) Ltd (NVLG.TA)?
What is the 3-year average PE Ratio for Novolog (Pharm-Up 1966) Ltd (NVLG.TA)?
What is the 5-year average PE Ratio for Novolog (Pharm-Up 1966) Ltd (NVLG.TA)?
How does the current PE Ratio for Novolog (Pharm-Up 1966) Ltd (NVLG.TA) compare to its historical average?